Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate CancerAlexander W. Wyatt, Kim N., Colin C. Collins et al.|JAMA Oncology|2016Cited by 384
Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation TherapyHimisha Beltran, Martin Gleave, Edmund C.P. Chedgy et al.|Clinical Cancer Research|2017Cited by 75